# Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer

Source: https://onco.cc/trials/nct07125391/  
OnCo record `nct07125391` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Propranolol, Paclitaxel / nab-paclitaxel and Carboplatin in Ovarian cancer, run by Bai-Rong Xia, now recruiting.

## Summary

Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer is a phase 2 interventional study registered as NCT07125391 by Bai-Rong Xia, with 136 participants planned, started 2025-06-20 and due to reach its primary completion in 2026-08-30. Interventions recorded: Propranolol Hydrochloride, Paclitaxel liposome, Carboplatin. Conditions recorded: Ovarian Cancer.

Linked to the drug Propranolol because the registry names it among its interventions and Ovarian cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07125391
- Phase: 2
- Setting: Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer: A Prospective, Multicenter, Phase II Clinical Study
- Sponsor: Bai-Rong Xia
- Enrolled: 136

## Sources

- ClinicalTrials.gov NCT07125391: https://clinicaltrials.gov/study/NCT07125391

## Connected records

- cancers: [Ovarian cancer](https://onco.cc/cancers/ovarian/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Paclitaxel / nab-paclitaxel](https://onco.cc/drugs/paclitaxel/), [Propranolol (Hemangeol)](https://onco.cc/drugs/propranolol-hemangeol/)

---
JSON: https://onco.cc/api/v1/entities/nct07125391.json